RHU GM-CSF shortens aplasia duration after ABMT in non-Hodgkin's lymphoma: a randomized placebo-controlled double-blind study.
Gorin
N C
NC
Hôpital Saint-Antoine, France.
Coiffier
B
B
Hayat
M
M
Philip
T
T
Vernant
J P
JP
Hervé
P
P
Colombat
P
P
Boivin
P
P
Slavin
S
S
Eugène-Jolchine
I
I
D016026:Bone Marrow Transplantation; D004311:Double-Blind Method; D006085:Graft Survival / Q000187:drug effects; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology / Q000627:therapeutic use*; D006410:Hematopoiesis / Q000187:drug effects*; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D007958:Leukocyte Count / Q000187:drug effects; D008228:Lymphoma, Non-Hodgkin / Q000601:surgery*; D009504:Neutrophils; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D014182:Transplantation, Autologous
D007155:Immunologic Factors; D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor